
Pancreatic cancer is one of the most dangerous cancers to treat, with low survival rates compared to other common forms. A new daily pill called daraxonrasib has shown encouraging results in early trials. When patients took this drug alongside chemotherapy, their tumors either shrank or stopped growing. For some patients, tumors became undetectable on scans. Doctors and cancer charities are calling this progress the biggest breakthrough in decades for people fighting this disease.
Kerr University™ subscribers
This lesson continues with the full article, natural-voice audio and discussion questions. Subscribers get every Daily News lesson, at every level.
New here? Book a free 30-minute class or try a free sample story.
Open the full interactive lesson with tap-to-hear on every word →